HUP9901346A3 - Deltap62, variants thereof, nucleic acid sequences and uses thereof - Google Patents

Deltap62, variants thereof, nucleic acid sequences and uses thereof

Info

Publication number
HUP9901346A3
HUP9901346A3 HU9901346A HUP9901346A HUP9901346A3 HU P9901346 A3 HUP9901346 A3 HU P9901346A3 HU 9901346 A HU9901346 A HU 9901346A HU P9901346 A HUP9901346 A HU P9901346A HU P9901346 A3 HUP9901346 A3 HU P9901346A3
Authority
HU
Hungary
Prior art keywords
deltap62
variants
nucleic acid
acid sequences
sequences
Prior art date
Application number
HU9901346A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of HUP9901346A2 publication Critical patent/HUP9901346A2/hu
Publication of HUP9901346A3 publication Critical patent/HUP9901346A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU9901346A 1995-06-01 1996-05-29 Deltap62, variants thereof, nucleic acid sequences and uses thereof HUP9901346A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations

Publications (2)

Publication Number Publication Date
HUP9901346A2 HUP9901346A2 (hu) 1999-08-30
HUP9901346A3 true HUP9901346A3 (en) 2000-10-30

Family

ID=9479588

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901346A HUP9901346A3 (en) 1995-06-01 1996-05-29 Deltap62, variants thereof, nucleic acid sequences and uses thereof

Country Status (15)

Country Link
US (1) US6544948B1 (hu)
EP (1) EP0828832A2 (hu)
JP (1) JPH11506325A (hu)
KR (1) KR19990022193A (hu)
AU (1) AU718889B2 (hu)
BR (1) BR9608632A (hu)
CA (1) CA2219861A1 (hu)
CZ (1) CZ291533B6 (hu)
FR (1) FR2734826B1 (hu)
HU (1) HUP9901346A3 (hu)
IL (1) IL118493A0 (hu)
NO (1) NO975409L (hu)
SK (1) SK283071B6 (hu)
WO (1) WO1996038556A2 (hu)
ZA (1) ZA964392B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2493300A (en) * 1999-01-06 2000-07-24 Regents Of The University Of California, The Modulation of hiv replication using sam68
PT1414960E (pt) 2001-07-30 2008-04-28 G R M O Groupe De Rech En Mala Doença óssea de paget
JP6193231B2 (ja) * 2011-08-08 2017-09-06 チュアラボ オンコロジー, インコーポレーテッドCurelab Oncology, Inc. がんの治療および予防のための、ｐ６２に関する方法および組成物
WO2021231652A1 (en) * 2020-05-14 2021-11-18 Curelab Oncology, Inc. Using the p62 plasmid to treat or reduce the severity of coronavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
KR100356615B1 (ko) * 1993-07-13 2003-04-03 아방티 파르마 소시에테 아노님 결함아데노바이러스벡터및유전자치료에서그의사용

Also Published As

Publication number Publication date
SK161397A3 (en) 1998-07-08
US6544948B1 (en) 2003-04-08
ZA964392B (en) 1996-12-09
FR2734826B1 (fr) 1997-07-04
WO1996038556A2 (fr) 1996-12-05
CA2219861A1 (fr) 1996-12-05
NO975409D0 (no) 1997-11-25
WO1996038556A3 (fr) 1997-01-09
MX9708877A (es) 1998-03-31
CZ291533B6 (cs) 2003-03-12
IL118493A0 (en) 1996-09-12
EP0828832A2 (fr) 1998-03-18
KR19990022193A (ko) 1999-03-25
HUP9901346A2 (hu) 1999-08-30
AU6129196A (en) 1996-12-18
SK283071B6 (sk) 2003-02-04
FR2734826A1 (fr) 1996-12-06
CZ375997A3 (cs) 1998-02-18
BR9608632A (pt) 1999-05-04
JPH11506325A (ja) 1999-06-08
NO975409L (no) 1997-11-25
AU718889B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
GB9507238D0 (en) Detecting dna sequence variations
GB9620769D0 (en) Nucleic acid sequencing
GB9515941D0 (en) DNA constructs
HK1012398A1 (en) Phosphonomonoester nucleic acids, methods for their preparation and their use
PL324880A1 (en) Dna constructs
EP0870832A4 (en) NEW DNA POLYMERASE
GB9408717D0 (en) DNA sequences
IL136349A0 (en) Virulence-associated nucleic acid sequences and uses thereof
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
ZA961082B (en) DNA sequence.
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
GB9526218D0 (en) DNA Sequences
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
HUT77435A (hu) Aminosavat tartalmazó nukleotid monomer analógok
HUP9901346A3 (en) Deltap62, variants thereof, nucleic acid sequences and uses thereof
AU6483896A (en) Nucleotide and amino acid sequence and uses thereof
GB9410170D0 (en) Nucleic acid
AU4931196A (en) Nucleic acid polyester polyamides
EP1007682A4 (en) INNOVATIVE NUCLEIC ACID MOLECULES AND THEIR USE
GB9519141D0 (en) DNA sequences
AU9449098A (en) Obtaining nucleic acid sequences
AU5539096A (en) Nucleic acid sequencing
GB9725630D0 (en) Charecterising nucleic acid
GB9701887D0 (en) Nucleic acid
GB9701886D0 (en) Nucleic acid

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees